These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 18891

  • 21. Nonstriatal dopaminergic neurons: Section XI. Dopaminergic neurons and mental diseases: Introduction: dopaminergic neurons and mental diseases.
    Bunney WE.
    Adv Biochem Psychopharmacol; 1977; 16():635-7. PubMed ID: 883562
    [No Abstract] [Full Text] [Related]

  • 22. Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function.
    Matthews RT, McMillen BA, Sallis R, Blair D.
    J Pharmacol Exp Ther; 1986 Oct; 239(1):124-31. PubMed ID: 2876091
    [Abstract] [Full Text] [Related]

  • 23. Dynorphin-immunoreactive terminals in the rat nucleus accumbens: cellular sites for modulation of target neurons and interactions with catecholamine afferents.
    Van Bockstaele EJ, Sesack SR, Pickel VM.
    J Comp Neurol; 1994 Mar 01; 341(1):1-15. PubMed ID: 7911809
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.
    Takashima H, Tsujihata M, Kishikawa M, Freed WJ.
    Exp Neurol; 1999 Sep 01; 159(1):98-104. PubMed ID: 10486178
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Presynaptic autoregulation of dopamine release].
    Zharikova AD, Godukhin OV.
    Fiziol Zh SSSR Im I M Sechenova; 1985 Jan 01; 71(1):105-12. PubMed ID: 2982672
    [Abstract] [Full Text] [Related]

  • 29. Dopaminergic innervation of pyramidal cells in the rat basolateral amygdala.
    Muller JF, Mascagni F, McDonald AJ.
    Brain Struct Funct; 2009 Feb 01; 213(3):275-88. PubMed ID: 18839210
    [Abstract] [Full Text] [Related]

  • 30. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS, Brown EM, Miller MS, Carswell S.
    J Pharmacol Exp Ther; 1999 Feb 01; 288(2):421-7. PubMed ID: 9918541
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Enhanced sensitivity of dopaminergic neurons to rotenone-induced toxicity with aging.
    Phinney AL, Andringa G, Bol JG, Wolters ECh, van Muiswinkel FL, van Dam AM, Drukarch B.
    Parkinsonism Relat Disord; 2006 May 01; 12(4):228-38. PubMed ID: 16488175
    [Abstract] [Full Text] [Related]

  • 33. Dopaminergic neurons: drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow.
    Walters JR, Roth RH.
    J Pharmacol Exp Ther; 1974 Oct 01; 191(1):82-91. PubMed ID: 4153880
    [No Abstract] [Full Text] [Related]

  • 34. Ultrastructural relations between nigrostriatal dopaminergic neurons and cholinergic nerve endings in the human brain.
    Anglade P, Tsuji S, Hirsch EC, Javoy-Agid F, Agid Y.
    Histol Histopathol; 1993 Jul 01; 8(3):501-4. PubMed ID: 8102915
    [Abstract] [Full Text] [Related]

  • 35. Effect of repeated treatment with neuroleptics on dopamine metabolism in cell bodies and terminals of dopaminergic systems in the rat brain.
    Scatton B.
    Adv Biochem Psychopharmacol; 1980 Jul 01; 24():31-6. PubMed ID: 6105783
    [No Abstract] [Full Text] [Related]

  • 36. Proceedings: Effects of alterations in impulse flow on transmitter metabolism in central dopaminergic neurons.
    Roth RH, Walters JR, Morgenroth VH.
    Psychopharmacol Bull; 1974 Jul 01; 10(3):40. PubMed ID: 4153706
    [No Abstract] [Full Text] [Related]

  • 37. Relevance of dopamine autoreceptors for psychiatry: preclinical and clinical studies.
    Meltzer HY.
    Schizophr Bull; 1980 Jul 01; 6(3):456-75. PubMed ID: 6105707
    [Abstract] [Full Text] [Related]

  • 38. Presynaptic dopamine autoreceptors and second messengers controlling tyrosine hydroxylase activity in rat brain.
    Onali P, Mosca E, Olianas MC.
    Neurochem Int; 1992 Mar 01; 20 Suppl():89S-93S. PubMed ID: 1365463
    [Abstract] [Full Text] [Related]

  • 39. Mesocortical dopaminergic neurons. 2. Electrophysiological consequences of terminal autoreceptor activation.
    Gariano RF, Sawyer SF, Tepper JM, Young SJ, Groves PM.
    Brain Res Bull; 1989 Mar 01; 22(3):517-23. PubMed ID: 2713724
    [Abstract] [Full Text] [Related]

  • 40. The function of presynaptic dopamine receptors on noradrenergic nerve terminals.
    Korczyn AD.
    Med Hypotheses; 1979 Oct 01; 5(10):1131-2. PubMed ID: 522699
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.